Kolmar BNH to ramp up production with new plant
Kolmar BNH, the health functional food developer and manufacturer under Kolmar Korea, announced Monday it has completed its third manufacturing plant in the city of Sejong, securing the largest annual production capacity in the industry.
The four-story plant, built on a site occupying some 20,024 square meters in Sejong, has a total floor area of 24,871 square meters.
The plant is capable of generating 1.8 billion units of solid-type health functional foods (tablets or pills) and 450 million packets of powder on an annual basis.
With the latest addition to its existing five plants, the company's total annual production capacity has now come to some 700 billion won ($537 million), the largest in the domestic industry.
The plant, together with the other two plants in Sejong, will share the production of solid-type HFF products with three of its existing factories in Eumseong County, North Chungcheong Province, which currently demonstrate a high operating rate, the company explained.
In July 2022, Kolmar unveiled a plan to build the latest plant with an investment of 57.7 billion won to fulfill rising demand for HFF both at home and abroad.
To maximize output, the new plant has also been equipped with a smart system.
Installed monitors track the entire production process, allowing for the real-time collection and analysis of data at each stage of production. The highly automated system also promptly corrects issues that arise during the production process, maintaining an optimized production environment.
The plant is set to be operational in the second half of 2024, the company added.
“With the completion of the latest plant in Sejong, we have enhanced our manufacturing capabilities, leaping forward as the leading HFF manufacturer with the largest annual production capacity in the industry,” said Kolmar BNH CEO Yoon Yeo-won.
“Moving forward, we will accelerate our foray overseas to solidify our position as a leading global production hub.”
下一篇:S. Korea entering 'recovery phase' amid geopolitical uncertainties: Choo
相关文章:
- 'Scent of Ink' to be performed at Kennedy Center in Washington
- LG Innotek wins patents for EV charging technology
- [New in Korean] Booker Prize
- [Obituary] Park Seo
- Try on traditional Korean costume during Hanbok Culture Week
- S. Korea joins ICRC's major donor group for 1st time
- [Obituary] Park Seo
- "당 망치는 응석받이"…안철수, 이준석 제명 서명운동 시작
- Posco Future M achieves 100% recycling of refractory waste
- BTS Jungkook's star
相关推荐:
- N. Korea threatens to strike US aircraft carrier
- Enhypen announces Nov. 17 comeback with 'Orange Blood'
- [KH Explains] Amazon's cloud industry plans raise fears of Korean market monopoly
- Seoul defense exhibition aims to boost arms exports
- Andong, serene destination for immersing in traditions
- Key ruling party officials offer to resign over by
- 공군 수송기 급파, 한·일 220명 텔아비브 탈출
- Foreigners turn net sellers of S. Korean stocks for 15 sessions
- Gyeongbokgung entrance platform, new signboard unveiled
- [KH Explains] Amazon's cloud industry plans raise fears of Korean market monopoly
- Blackpink's Jennie makes solo debut on Official UK Singles Chart
- Returning minister Yu In
- [New in Korean] Witches, ecofeminism, climate crisis: Tale of resilience and nature’s power
- Returning minister Yu In
- [New in Korean] Witches, ecofeminism, climate crisis: Tale of resilience and nature’s power
- Choo calls for end to protectionism, supply chain recovery during G20 meeting
- HD Korea Shipbuilding to build world's first ammonia
- Seoul to implement alert system to manage overcrowded areas
- New book sheds light on ongoing debate and legacy of comfort women issues
- Japan thanks S. Korea for Israel rescue effort
- Hyundai Mobis Q3 net jumps 78% on sales growth of key components
- 탄약 찾는 러…국방부 "北컨테이너 적재량, 포탄 수십만발 분량"
- Prestige Biopharma eyes complete value chain
- Seoul shares open sharply lower on US losses
- LG Electronics to bolster local strategies, B2B push to widen gap with Chinese rivals
- Cirque Du Soleil mesmerizes Seoul with 'Luzia: A Waking Dream of Mexico'
- Seventeen 1st K
- Samsung Biologics quarterly sales hit W1tr for first time
- 여권 ‘TK 지지율’ 비상…오늘 서울 오는 박근혜에 주목
- 홍준표 "난 죄 지은 것 없다, 인요한 사면 논의 자체가 쪽팔려"